Wells Fargo & Company Virios Therapeutics, Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Virios Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 133 shares of VIRI stock, worth $30. This represents 0.0% of its overall portfolio holdings.
Number of Shares
133
Previous 130
2.31%
Holding current value
$30
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding VIRI
# of Institutions
22Shares Held
681KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA209KShares$48,0430.0% of portfolio
-
Geode Capital Management, LLC Boston, MA174KShares$40,1270.0% of portfolio
-
State Street Corp Boston, MA52.8KShares$12,1500.0% of portfolio
-
Mc Collum Christoferson Group LLC Amherst, NY42KShares$9,6600.01% of portfolio
-
Raymond James & Associates St Petersburg, FL30KShares$6,9000.0% of portfolio
About Virios Therapeutics, Inc.
- Ticker VIRI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,330,400
- Market Cap $4.22M
- Description
- Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...